Finance

Lists
Why is SMGR up 3,80%?
Dive Deeper
SMGR:IDX
Semen Indonesia (Persero) Tbk PT
IDR 1 640,00
+3,80%
(+60,00) 1D
12 Okt., 16:14:57 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for SMGR...
Open
IDR 1 590
High
IDR 1 645
Low
IDR 1 590
Mkt. cap
11,07 bn
Avg. vol.
25,26 m
Volume
30,77 m
Dividend
1,73%
Quarterly dividend
IDR 7
Ex-dividend date
21 Mei 2026
P/E ratio
29,21
52-wk high
IDR 3 260
52-wk low
IDR 1 380
EPS
IDR 56
Shares outstanding
6,75 mjd
No. of employees
9 k
Open
IDR 1 590
High
IDR 1 645
Low
IDR 1 590
Mkt. cap
11,07 bn
Avg. vol.
25,26 m
Volume
30,77 m
Dividend
1,73%
Quarterly dividend
IDR 7
Ex-dividend date
21 Mei 2026
P/E ratio
29,21
52-wk high
IDR 3 260
52-wk low
IDR 1 380
EPS
IDR 56
Shares outstanding
6,75 mjd
No. of employees
9 k
News stories
From web sources and news partners
Profile
PT Semen Indonesia Tbk is a state-owned holding company providing building material solutions. The company has 17 subsidiaries located in Indonesia and Vietnam. With a market reach to Asia, Australia and Oceania, the company's main business is in the cement sector and its derivative products such as concrete, mortar, precast, and aggregate. In running its main business process, the company has supporting business lines such as construction and manufacturing services, land and sea transportation services, industrial packaging provider, mining services, international trade service, and building material solution applications. In addition, through several subsidiaries and business units, the company also does business in property, industrial estate management, industrial waste management, informatics solutions, and health services. Wikipedia
About Semen Indonesia (Persero) Tbk PT
CEO-
Employees8,66 k
Founded1957
HeadquartersGresik Regency, Oos-Java, Indonesië
SectorBuilding material
Websitesig.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
9,70 bn
9,94 bn
8,29 bn
9,36 bn
Cost of goods sold
7,87 bn
7,94 bn
6,64 bn
7,25 bn
Cost of revenue
7,87 bn
7,94 bn
6,64 bn
7,25 bn
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,34 bn
1,56 bn
1,32 bn
1,77 bn
Operating expense
1,45 bn
1,64 bn
1,39 bn
1,83 bn
Total operating expenses
9,32 bn
9,58 bn
8,03 bn
9,07 bn
Operating income
378,86 mjd
362,55 mjd
258,64 mjd
286,71 mjd
Other non operating income
-7,33 mjd
-2,76 mjd
-6,43 mjd
-7,98 mjd
EBT including unusual items
219,28 mjd
227,36 mjd
156,30 mjd
236,09 mjd
EBT excluding unusual items
227,72 mjd
223,76 mjd
155,41 mjd
219,71 mjd
Income tax expense
96,37 mjd
208,75 mjd
89,69 mjd
95,69 mjd
Effective tax rate
43,95%
91,81%
57,38%
40,53%
Other operating expenses
112,08 mjd
79,35 mjd
68,16 mjd
57,47 mjd
Net income
74,86 mjd
76,01 mjd
80,34 mjd
147,91 mjd
Net profit margin
0,77%
0,76%
0,97%
1,58%
Earnings per share
11,00
11,00
12,00
22,00
Interest and investment income
49,37 mjd
60,18 mjd
56,67 mjd
53,20 mjd
Interest expense
-198,38 mjd
-191,87 mjd
-165,80 mjd
-155,11 mjd
Net interest expenses
-149,00 mjd
-131,70 mjd
-109,14 mjd
-101,91 mjd
Depreciation and amortization charges
-
-
-
-
EBITDA
1,08 bn
1,10 bn
950,68 mjd
941,89 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme